[{"id":"0d569526-0a1b-477a-bbb0-9fbb8b295214","acronym":"ARCADIAN","url":"https://clinicaltrials.gov/study/NCT04648033","created_at":"2021-01-19T20:40:00.018Z","updated_at":"2024-07-02T16:34:25.606Z","phase":"Phase 1","brief_title":"Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC","source_id_and_acronym":"NCT04648033 - ARCADIAN","lead_sponsor":"University of Oxford","biomarkers":" MIR210","pipe":"","alterations":" ","tags":["MIR210"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • vinorelbine tartrate • atovaquone"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 12/07/2020","start_date":" 12/07/2020","primary_txt":" Primary completion: 10/02/2023","primary_completion_date":" 10/02/2023","study_txt":" Completion: 10/02/2023","study_completion_date":" 10/02/2023","last_update_posted":"2024-06-17"}]